Genetic Alteration of a Bispecific Ligand-Directed Toxin Targeting Human CD19 and CD22 Receptors Resulting in Improved Efficacy Against Systemic B Cell Malignancy

Leukemia Research - United Kingdom
doi 10.1016/j.leukres.2009.02.006

Related search